Five years ago, almost every large Australian corporation announced an innovation lab, digital accelerator, or venture studio. The goal was to develop new business models, experiment with emerging technology, and drive cultural change toward innovation.

In 2026, most of these initiatives have either shut down quietly or been dramatically scaled back. The few that survive produce modest results that don’t justify their cost. Innovation theatre replaced genuine innovation.

What went wrong, and what would actually work better?

The Structural Problems

Corporate innovation labs usually face contradictory mandates. They’re supposed to experiment and take risks, but they report into corporate structures that punish failure. They’re meant to move quickly, but they need approvals through layers of management that slow everything down. They’re intended to challenge existing business models, but the people funding them have careers tied to those models.

These contradictions create paralysis. Innovation teams propose ideas that get watered down through approval processes until they’re no longer innovative. Or they pursue genuinely novel ideas that get killed because they might cannibalise existing revenue.

The Talent Problem

Corporations often staff innovation labs with internal transfers — people from existing business units who volunteer or get nominated for innovation roles. These people understand the business but usually lack startup experience, product development expertise, or comfort with failure.

The alternative is hiring external innovation professionals. But the best external candidates command startup equity and autonomy. They’re not interested in corporate roles that offer neither. The people willing to join corporate innovation labs are often not the ones who can drive genuine innovation.

The Incentive Misalignment

Corporate executives are typically on three-to-five-year tenures. Their incentives favour initiatives that show results within that timeframe. Innovation labs produce tangible results on longer timelines — usually five to ten years from concept to scaled new business.

This creates a mismatch. The executive who launches an innovation lab wants to show ROI during their tenure. The innovation lab needs longer to deliver meaningful outcomes. The result is pressure to demonstrate quick wins, which leads to incremental projects rather than transformative innovation.

The Culture Clash

Startups iterate quickly, embrace failure as learning, and make decisions with incomplete information. Corporations have compliance requirements, risk management processes, and decision-making frameworks that evolved to manage large-scale operations safely.

Trying to run a startup inside a corporate environment means either adopting startup practices (which creates compliance and risk issues) or following corporate processes (which eliminates the speed and flexibility that startups require). Most innovation labs end up in an uncomfortable middle ground where they have startup expectations but corporate constraints.

The Business Model Trap

Many innovation lab projects fail the “so what?” test. A team develops an interesting technology or service, but when asked who will pay for it and how it fits into the corporate portfolio, the answers are vague.

Some projects are solutions looking for problems — interesting technology that doesn’t solve a clear customer pain point. Others solve real problems but for markets the corporation doesn’t understand or can’t access with existing capabilities.

Without clear paths to revenue and integration with core business, innovation projects become expensive experiments that deliver learning but not commercial outcomes.

What Actually Works

Some corporate innovation initiatives succeed. They share common characteristics:

Clear mandate and metrics. Successful programs have explicit goals — develop new revenue streams in specific markets, acquire particular capabilities, or explore defined technology areas. Vague mandates to “drive innovation” don’t provide enough direction.

Executive protection. A senior executive with long tenure and genuine commitment provides political cover for the innovation team. This person protects the team from premature evaluation and allows necessary experimentation.

Separate organisational structure. The innovation team operates semi-independently with its own P&L, decision-making authority, and culture. It reports to a corporate board but isn’t embedded in existing business units that might sabotage it.

Patient capital. The corporation commits to multi-year investment without expecting quick returns. This allows proper product development and market testing rather than forcing premature commercialisation.

Partnerships with startups. Rather than building everything internally, successful corporate innovation involves partnering with, acquiring, or investing in external startups. This accesses innovation expertise without trying to replicate startup culture corporately.

The Alternative Models

Instead of innovation labs, some corporations are trying different approaches:

Corporate venture capital. Invest in external startups aligned with strategic interests. This provides exposure to innovation, option value on technologies that might matter later, and learning without trying to build internally.

Acqui-hiring innovative companies. Buy small companies for their teams and capabilities rather than trying to build those capabilities from scratch. This brings innovation expertise into the organisation directly.

Partnerships and pilots. Work with technology vendors and startups on pilot projects that test new approaches without committing to long-term internal development. Learn quickly, scale what works, abandon what doesn’t.

Innovation challenges and hackathons. Engage employees across the organisation in time-bound innovation activities. This distributes innovation across the company rather than isolating it in a lab.

These approaches avoid the structural problems of innovation labs by not trying to create a persistent startup-like organisation inside a corporate structure.

The Learning Fallacy

Innovation labs are often justified as learning initiatives even when commercial outcomes don’t materialise. “We learned a lot about blockchain” or “We now understand customer needs in this market.”

This learning justification is often post-hoc rationalisation for failed commercial initiatives. The learning could usually be acquired more cheaply through consulting engagements, academic partnerships, or small pilot projects rather than multi-year internal programs.

Real learning happens through doing, but expensive doing without clear commercial goals is usually inefficient.

Who Benefits From Innovation Theatre

Innovation labs serve purposes beyond innovation:

Marketing and recruitment. “We have an innovation lab” signals to customers and recruits that the company is forward-thinking. This has value even if the lab produces little.

Internal politics. Executives launch innovation initiatives to demonstrate vision and secure budget. The initiatives don’t need to succeed to serve this purpose.

Delayed decision-making. When faced with disruptive technology or business model changes, launching an innovation lab allows executives to appear responsive without making difficult strategic decisions immediately.

These motivations aren’t necessarily cynical, but they explain why innovation labs persist despite poor results. They serve organisational purposes even when they don’t deliver innovation.

What Corporations Should Do Instead

For corporations genuinely wanting to drive innovation:

Focus on core business innovation. Improve existing products, processes, and customer experiences. Incremental innovation in core business often delivers more value than attempts at radical innovation in unfamiliar markets.

Invest in external innovation through venture capital or partnerships. Access innovation without trying to replicate startup conditions internally.

Build acquisition and integration capabilities. Develop expertise in identifying, acquiring, and integrating innovative smaller companies. This is a more reliable path to new capabilities than internal development.

Create space for intrapreneurship. Allow employees to pursue innovative ideas within their business units with appropriate support. This distributes innovation rather than concentrating it in a lab.

Be honest about constraints. Acknowledge that corporate structures, risk tolerance, and incentives make certain types of innovation difficult. Focus on innovation approaches compatible with corporate realities rather than pretending corporations can act like startups.

My Take

The corporate innovation lab model has largely failed because it tries to create startup conditions inside organisations structurally incompatible with startup approaches. The few that succeed do so despite the model, not because of it.

Corporations need innovation, but the path isn’t creating isolated labs staffed with people who don’t have startup expertise and asking them to generate transformative new business models while navigating corporate approval processes.

Better approaches involve engaging with external innovation ecosystems through investment, partnership, and acquisition. Or distributing innovation across the organisation rather than isolating it. Or focusing innovation efforts on core business improvement where corporate capabilities provide genuine advantage.

The innovation lab model will probably persist because it serves organisational purposes beyond innovation. But realistic executives should treat these initiatives as expensive signalling rather than genuine sources of transformative innovation. If you want real innovation, look elsewhere.